← Companies|AIIMS New Delhi
AI

AIIMS New Delhi

NPNew Delhi INFounded 19568,000 employees
Private CapacadPrivateOncologyCardiology
Platform: Teaching Hosp
Market Cap
N/A
All Drugs
8
Clinical Trials
8
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (8 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
AII-IIT-890AII-IIT-890Approved1mRNAPD-L1EZH2iProstate Ca
AII-IIT-938AII-IIT-938Preclinical1Bispecific AbWEE1RAS(ON)iDravet
AII-IIT-903AII-IIT-903NDA/BLA1ASOGPRC5DPARPiEoE
AII-IIT-879AII-IIT-879Preclinical1Fusion ProteinTIGITAuroraAiHS
AII-IIT-540AII-IIT-540Phase 1/21Gene EditingKRASG12DBCL-2iNASH
AII-IIT-782AII-IIT-782Phase 2/31RadioligandEZH2BCMA ADCALS
AII-IIT-727AII-IIT-727Phase 2/31ADCSGLT2CAR-T CD19Pompe
AII-IIT-336AII-IIT-336Preclinical1ADCBiTENB
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)
2026-04-19
AII-IIT-879 Orphan Drug
HS
Orphan Drug
2026-09-19
AII-IIT-879 Interim
HS
Interim
2027-12-26
AII-IIT-903 Ph3 Readout
EoE
Ph3 Readout
2028-11-10
AII-IIT-727 Ph3 Readout
Pompe
Ph3 Readout
2029-05-19
AII-IIT-890 Ph3 Readout
Prostate Ca
Ph3 Readout
2030-03-18
AII-IIT-938 Interim
Dravet
Interim
2031-01-10
AII-IIT-336 Interim
NB
Interim
2031-07-27
AII-IIT-540 Ph2 Data
NASH
Ph2 Data